in the medullary thick ascending limb of Henle (MTALH) contributes to NaCl balance and is also responsible for the creation of medullary interstitial hypertonicity. Despite the presence of angiotensin II subtype 1 (AT1) receptors in both the luminal and the basolateral plasma membranes of MTALH cells, no information is available on the effect of angiotensin II on NaCl reabsorption in MTALH and, furthermore, on angiotensin II-dependent medullary interstitial osmolality. MTALHs from male Sprague-Dawley rats were isolated and microperfused in vitro; transepithelial net chloride absorption (JCl) as well as transepithelial voltage (V te) were measured. Luminal or peritubular 10 Ϫ11 and 10 Ϫ10 M angiotensin II had no effect on JCl or V te. However, 10 Ϫ8 M luminal or peritubular angiotensin II reversibly decreased both J Cl and Vte. The effect of both luminal and peritubular angiotensin II was prevented by the presence of losartan (10 Ϫ6 M). By contrast, PD-23319, an AT 2-receptor antagonist, did not alter the inhibitory effect of 10 Ϫ8 M angiotensin II. Finally, no additive effect of luminal and peritubular angiotensin II was observed. We conclude that both luminal and peritubular angiotensin II inhibit NaCl absorption in the MTALH via AT1 receptors. Because of intrarenal angiotensin II synthesis, angiotensin II concentration in medullary tubular and interstitial fluids may be similar in vivo to the concentration that displays an inhibitory effect on NaCl reabsorption under the present experimental conditions. in vitro microperfusion; renal tubule; NaCl transport; angiotensin II subtype 1; losartan ANGIOTENSIN II IS A POTENT regulator of extracellular fluid volume, mainly through its direct effects on renal tubular sodium reabsorption, as well as on aldosterone synthesis. Acute systemic infusion of low-dose angiotensin II stimulates overall tubular sodium reabsorption and decreases urine sodium excretion, independently of changes in renal or systemic hemodynamics (5, 15). In rat experiments using in vivo superficial tubule microperfusion, systemic angiotensin II infusion at 20 ng⅐kg Ϫ1 ⅐min Ϫ1 , which achieves a subpressor, physiological plasma concentration (picomolar range), stimulates proximal water and NaCl reabsorption (24). Conversely, saralazin infusion, which suppresses endogenous angiotensin II activity, inhibits proximal tubule absorption (24). In addition, endogenously produced angiotensin II is responsible for a nanomolar intratubular angiotensin II concentration that stimulates proximal sodium reabsorption (33). In the more distal part of the nephron, angiotensin II also directly stimulates sodium reabsorption by activating Na ϩ /H ϩ exchange and the amiloridesensitive Na ϩ channel (2, 23, 37). Finally, angiotensin II stimulates aldosterone synthesis and thereby indirectly enhances sodium reabsorption via the epithelial sodium channel in the cortical collecting duct (26) and likely via the thiazidesensitive sodium-chloride cotransporter in the distal convoluted tubule (21).In the loop of Henle, available...